Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in

Shuang Wu1, Tatsuo Kanda, Shingo Nakamoto

  • 1Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Chuo-ku, Chiba, Japan.

Anticancer Research
|September 21, 2012
PubMed
Abstract

Insights

Receptor-interacting serine/threonine protein kinase-2 (RIPK2) knockdown reduced epithelial-to-mesenchymal transition (EMT) gene expression in liver cancer cells. This suggests RIPK2 influences hepatic cell migration and could impact liver carcinogenesis and regeneration.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Receptor-interacting serine/threonine protein kinase-2 (RIPK2) is implicated in tumor progression, differentiation, and wound repair.
  • Investigating RIPK2's role in hepatocellular carcinoma (HCC) is crucial for understanding liver cancer development.

Purpose of the Study:

  • To determine the effect of RIPK2 knockdown on epithelial-to-mesenchymal transition (EMT)-associated gene expression in human hepatoma cells.
  • To elucidate RIPK2's potential role in hepatic cell migration.

Main Methods:

  • Generated HepG2 cells with stable RIPK2 knockdown using shRNA (HepG2-shRIPK2).
  • Utilized PCR-based arrays to compare the expression of 84 EMT-associated genes between HepG2-shRIPK2 and control cells.

Main Results:

  • RIPK2 knockdown significantly down-regulated mRNA expression of key EMT markers including JAG1, PAI1, CDH1, SNAI2, KRT19, VIM, and SIP1.
  • Specifically, nuclear factor kappa B (NF-κB)-dependent PAI1 and VIM gene expressions were reduced upon RIPK2 knockdown.

Conclusions:

  • RIPK2 plays a role in regulating EMT-associated gene expression in hepatoma cells.
  • RIPK2 knockdown affects hepatic cell migration, suggesting its involvement in liver carcinogenesis and regeneration processes.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...